-
4m 23sPart 1 | Session 1 POTTER: Oesophageal Fistulae in Catheter Ablation Patients
-
4m 26sPart 1 | Session 2 AdaptResponse: AdaptivCRT® Algorithm in Synchronized LV Pacing
-
6m 49sPart 1 | Session 3 MANIFEST-PF: Real-world Experience of PFA in Commercial Practice
-
6m 26s
-
2m 38sPart 1 | Session 5 TEMPO-HCM: Extended ECG Monitoring in HCM
-
3m 37sPart 1 | Session 6 Conformable PVI Catheter for Pulmonary Vein Isolation
-
3m 54sPart 1 | Session 7 BRUGADA Randomized: Epidcardial Ablation to Prevent Sudden Death
-
6m 25sPart 2 | Session 1 5 Trials That Will Change Your Practice With Dr Sohaib
-
6m 24sPart 2 | Session 2 4 Trials That Will Change Your Practice With Dr Di Biase
-
54sPart 3 | Session 1 Dr Bergonti: Pulsed-Field Ablation & Reasons to Research
-
1m 52sPart 3 | Session 2 Dr Bruce Wilkoff: Therapy Morbidity and Advice to Young Researchers
-
31sPart 3 | Session 3 Dr Carlo Pappone: Advice to Early-Career Electrophysiologists
-
28sPart 3 | Session 4 Dr Juan Caro Codon: Building a Team For Success
In this short interview, Dr Vivek Reddy discusses his excitement for the advent of pulsed-field ablation and his advice for early-career electrophysiologists.
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice.
More from this programme
Part 1
Expert Interviews
Part 2
Featured Highlights
In these concise overviews, selected faculty provide their thoughts on the most impactful trials from EHRA 2023.
Faculty Biographies
Vivek Reddy
Director of Cardiac Arrhythmia Services
Dr Vivek Y. Reddy is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and Director of Electrophysiology for the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai.
Dr Reddy is one of the US's premier cardiac electrophysiologists. He leads a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias and heart failure, including catheter ablation for atrial fibrillation and ventricular tachycardia, and device therapies for stroke prevention. Under his leadership, Mount Sinai is the lead investigational site for many multinational clinical trials exploring new arrhythmia procedures and technologies, most recently pulsed field ablation to treat atrial fibrillation. Moreover, in 2014, he implanted the world’s first miniature leadless pacemaker, as well as the first leadless pacemaker in…
Comments